Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02099 | 34508436 | JNMA J Nepal Med Assoc | Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study. | 2021 | Details |
| A02100 | 34508238 | Nat Rev Gastroenterol Hepatol | Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. | 2021 | Details |
| A02110 | 34503976 | Mol Pharmacol | Construction and Characterization of CRISPR/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene. | 2021 | Details |
| A02118 | 34500407 | Curr Opin Pharmacol | A double-edged sword: The Kelch-like ECH-associated protein 1-nuclear factor erythroid-derived 2-related factor 2-antioxidant response element pathway targeted pharmacological modulation in nonalcoholic fatty liver disease. | 2021 | Details |
| A02123 | 34498307 | Phytother Res | The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double-blind clinical trial. | 2021 | Details |
| A02126 | 34497431 | World J Gastroenterol | Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease. | 2021 | Details |
| A02127 | 34497333 | Sci Rep | Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease. | 2021 | Details |
| A02133 | 34494384 | Hepatol Commun | Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis. | 2021 | Details |
| A02138 | 34491336 | J Clin Endocrinol Metab | Nonalcoholic Fatty Liver Disease in Women and Girls With Polycystic Ovary Syndrome. | 2022 | Details |
| A02153 | 34484560 | Oxid Med Cell Longev | Dietary Valine Ameliorated Gut Health and Accelerated the Development of Nonalcoholic Fatty Liver Disease of Laying Hens. | 2021 | Details |
| A02157 | 34482357 | Med Sci Monit | Live Combined B. subtilis and E. faecium Alleviate Liver Inflammation, Improve Intestinal Barrier Function, and Modulate Gut Microbiota in Mice with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02158 | 34482352 | AIDS | Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virus. | 2021 | Details |
| A02165 | 34478730 | Arch Biochem Biophys | Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis. | 2021 | Details |
| A02174 | 34474519 | Endocrinol Metab (Seoul) | Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability. | 2021 | Details |
| A02178 | 34473313 | Methods Mol Biol | Therapeutic Effects of Resveratrol on Nonalcoholic Fatty Liver Disease Through Inflammatory, Oxidative Stress, Metabolic, and Epigenetic Modifications. | 2022 | Details |
| A02184 | 34470675 | Br J Nutr | Diet containing dehulled adlay ameliorates hepatic steatosis, inflammation and insulin resistance in rats with non-alcoholic fatty liver disease. | 2021 | Details |
| A02194 | 34465857 | Int J Obes (Lond) | Obese mice weight loss role on nonalcoholic fatty liver disease and endoplasmic reticulum stress treated by a GLP-1 receptor agonist. | 2021 | Details |
| A02196 | 34464909 | Diabetes Metab Syndr | Retrospective analysis (2009-2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India. | 2021 | Details |
| A02199 | 34463983 | Periodontol 2000 | Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis. | 2021 | Details |
| A02208 | 34459959 | Eur J Pediatr | Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial. | 2021 | Details |
| A02211 | 34459096 | Liver Int | Changing clinical management of NAFLD in Asia. | 2021 | Details |
| A02212 | 34459004 | J Food Biochem | Chlorella vulgaris is an effective supplement in counteracting non-alcoholic fatty liver disease-related complications through modulation of dyslipidemia, insulin resistance, and inflammatory pathways. | 2021 | Details |
| A02216 | 34456329 | Med Sci Monit | A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health. | 2021 | Details |
| A02231 | 34453052 | Nat Commun | The pesticide chlorpyrifos promotes obesity by inhibiting diet-induced thermogenesis in brown adipose tissue. | 2021 | Details |
| A02233 | 34450307 | Pharmacol Res | Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis. | 2021 | Details |
| A02237 | 34449768 | PLoS One | Association of IRS1 (Gly972Arg) and IRS2 (Gly1057Asp) genes polymorphisms with OSA and NAFLD in Asian Indians. | 2021 | Details |
| A02247 | 34447378 | Front Immunol | Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression. | 2021 | Details |
| A02250 | 34446275 | Maturitas | The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. | 2021 | Details |
| A02251 | 34446271 | Clin Ther | Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02253 | 34446002 | Lipids Health Dis | Sirtuin3 rs28365927 functional variant confers to the high risk of non-alcoholic fatty liver disease in Chinese Han population. | 2021 | Details |
| A02262 | 34444750 | Nutrients | Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease. | 2021 | Details |
| A02265 | 34443333 | Molecules | Phenolics-Rich Extracts of Dietary Plants as Regulators of Fructose Uptake in Caco-2 Cells via GLUT5 Involvement. | 2021 | Details |
| A02267 | 34441497 | Foods | Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review. | 2021 | Details |
| A02268 | 34441028 | Medicina (Kaunas) | Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions. | 2021 | Details |
| A02271 | 34440803 | Cells | NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome. | 2021 | Details |
| A02275 | 34440507 | Life (Basel) | Association of Nonalcoholic Hepatic Fibrosis with Body Composition in Female and Male Psoriasis Patients. | 2021 | Details |
| A02276 | 34440495 | Life (Basel) | Differences among Three Skeletal Muscle Mass Indices in Predicting Non-Alcoholic Fatty Liver Disease: Korean Nationwide Population-Based Study. | 2021 | Details |
| A02290 | 34434943 | Front Med (Lausanne) | Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update. | 2021 | Details |
| A02295 | 34433228 | Hepatology | Up-regulation of thioesterase superfamily member 2 in skeletal muscle promotes hepatic steatosis and insulin resistance in mice. | 2021 | Details |
| A02297 | 34432804 | PLoS One | Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study. | 2021 | Details |
| A02300 | 34431493 | J Clin Endocrinol Metab | LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia. | 2022 | Details |
| A02306 | 34426744 | Evid Based Complement Alternat Med | Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver. | 2021 | Details |
| A02307 | 34426178 | J Integr Med | Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease. | 2021 | Details |
| A02312 | 34423525 | Int J Clin Pract | Omega 3-rich Camelina sativa oil in the context of a weight loss program improves glucose homeostasis, inflammation and oxidative stress in patients with NAFLD: A randomised placebo-controlled clinical trial. | 2021 | Details |
| A02326 | 34417811 | Endocrinology | Rosiglitazone Requires Hepatocyte PPARγ Expression to Promote Steatosis in Male Mice With Diet-Induced Obesity. | 2021 | Details |
| A02343 | 34410573 | Dig Dis Sci | A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02347 | 34407600 | Diabetes Metab J | Carnitine Orotate Complex Ameliorates Insulin Resistance and Hepatic Steatosis Through Carnitine Acetyltransferase Pathway. | 2021 | Details |
| A02348 | 34407548 | Exp Clin Endocrinol Diabetes | Hepatic Meteorin-like and Krüppel-like Factor 3 are Associated with Weight Loss and Liver Injury. | 2021 | Details |
| A02352 | 34406209 | Braz J Med Biol Res | α,β-Amyrin prevents steatosis and insulin resistance in a high-fat diet-induced mouse model of NAFLD via the AMPK-mTORC1-SREBP1 signaling mechanism. | 2021 | Details |
| A02353 | 34406004 | J Agric Food Chem | Baicalein Enhances the Effect of Acarbose on the Improvement of Nonalcoholic Fatty Liver Disease Associated with Prediabetes via the Inhibition of De Novo Lipogenesis. | 2021 | Details |
| A02362 | 34402795 | JMIR Form Res | Utilization of a Directly Supervised Telehealth-Based Exercise Training Program in Patients With Nonalcoholic Steatohepatitis: Feasibility Study. | 2021 | Details |
| A02365 | 34401690 | JHEP Rep | Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication. | 2021 | Details |
| A02367 | 34400897 | Int J Med Sci | Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes. | 2021 | Details |
| A02387 | 34393826 | Front Physiol | Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD. | 2021 | Details |
| A02398 | 34387409 | Diabetes Obes Metab | A clinical overview of non-alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know. | 2021 | Details |
| A02399 | 34386935 | Hepatol Int | First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients. | 2021 | Details |
| A02406 | 34384565 | J Pharmacol Sci | Protective effect of SGL5213, a potent intestinal sodium-glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice. | 2021 | Details |
| A02412 | 34382947 | Am J Gastroenterol | Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02428 | 34374253 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | [Effects of GPR81 agonist on insulin resistance in rats with nonalcoholic fatty liver disease]. | 2021 | Details |
| A02429 | 34374198 | J Dig Dis | Serum syndecan-4 is associated with nonalcoholic fatty liver disease. | 2021 | Details |
| A02432 | 34372774 | BMC Gastroenterol | Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study. | 2021 | Details |
| A02435 | 34371968 | Nutrients | The Emerging Role of Sfrp5 and Wnt5a in the Pathogenesis of Obesity: Implications for a Healthy Diet and Lifestyle. | 2021 | Details |
| A02436 | 34371959 | Nutrients | Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS). | 2021 | Details |
| A02440 | 34371198 | Prostaglandins Other Lipid Mediat | Lipocalin-type Prostaglandin D2 Synthase appears to function as a Novel Adipokine Preventing Adipose Dysfunction in response to a High Fat Diet. | 2021 | Details |
| A02441 | 34371126 | J Nutr Biochem | Dietary citrate acutely induces insulin resistance and markers of liver inflammation in mice. | 2021 | Details |
| A02442 | 34370929 | Biomol Concepts | Insulin resistance is positively associated with plasma cathepsin D activity in NAFLD patients. | 2021 | Details |
| A02444 | 34370215 | World J Pediatr | Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity. | 2021 | Details |
| A02445 | 34369032 | J Biochem Mol Toxicol | Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice. | 2021 | Details |
| A02446 | 34368214 | Front Nutr | Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A02448 | 34367500 | World J Hepatol | Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States' adolescent population. | 2021 | Details |
| A02451 | 34366846 | Front Pharmacol | Metformin Alleviates Hepatic Steatosis and Insulin Resistance in a Mouse Model of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Promoting Transcription Factor EB-Dependent Autophagy. | 2021 | Details |
| A02460 | 34364544 | Lancet Gastroenterol Hepatol | Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. | 2021 | Details |
| A02461 | 34363981 | Diabetes Metab | Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement. | 2021 | Details |
| A02463 | 34363644 | Mol Nutr Food Res | Oral Spermidine Targets Brown Fat and Skeletal Muscle to Mitigate Diet-Induced Obesity and Metabolic Disorders. | 2021 | Details |
| A02471 | 34360773 | Int J Mol Sci | Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics. | 2021 | Details |
| A02475 | 34359991 | Cells | A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies. | 2021 | Details |
| A02487 | 34356308 | Antioxidants (Basel) | Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism. | 2021 | Details |
| A02489 | 34355342 | Endocrine | Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus. | 2021 | Details |
| A02516 | 34344058 | Diabetes Metab Res Rev | Serum creatinine levels and risk of nonalcohol fatty liver disease in a middle-aged and older Chinese population: A cross-sectional analysis. | 2021 | Details |
| A02517 | 34343577 | Metabolism | Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease. | 2021 | Details |
| A02520 | 34342231 | J Agric Food Chem | Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease via Inhibiting the mTORC1/SREBP-1c Pathway. | 2021 | Details |
| A02527 | 34340957 | Endocrinol Diabetes Nutr (Engl Ed) | Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity. | 2021 | Details |
| A02535 | 34337376 | Metabol Open | The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease. | 2021 | Details |
| A02544 | 34333285 | Biomed Pharmacother | Protective effects of p-coumaric acid against high-fat diet-induced metabolic dysregulation in mice. | 2021 | Details |
| A02553 | 34330512 | Clin Nutr ESPEN | Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. | 2021 | Details |
| A02558 | 34328446 | Am J Gastroenterol | The Changing Epidemiology of Liver Disease Among US Children and Adolescents From 1999 to 2016. | 2021 | Details |
| A02564 | 34327606 | Endocrine | Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats. | 2021 | Details |
| A02567 | 34326946 | World J Diabetes | Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor. | 2021 | Details |
| A02579 | 34324263 | Diabetes Obes Metab | Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. | 2021 | Details |
| A02588 | 34321846 | World J Gastroenterol | Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics. | 2021 | Details |
| A02590 | 34321567 | Sci Rep | High frequency and long persistency of ballooning hepatocyte were associated with glucose intolerance in patients with severe obesity. | 2021 | Details |
| A02595 | 34321005 | Lipids Health Dis | Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population. | 2021 | Details |
| A02598 | 34320173 | Am J Clin Nutr | The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials. | 2021 | Details |
| A02601 | 34314787 | Adv Drug Deliv Rev | Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. | 2021 | Details |
| A02609 | 34311022 | Diabetes Res Clin Pract | Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial. | 2021 | Details |
| A02622 | 34306045 | PPAR Res | Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-α/γ) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02629 | 34303827 | Clin Res Hepatol Gastroenterol | Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study. | 2021 | Details |
| A02633 | 34300354 | J Clin Med | Albuminuria Is Associated with Hepatic Iron Load in Patients with Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome. | 2021 | Details |
| A02635 | 34300227 | J Clin Med | Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02638 | 34299336 | Int J Mol Sci | Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. | 2021 | Details |